Natco Pharma announced closure of inspection with an Establishment Inspection Report (EIR) from USFDA for the pre-approval inspection conducted at its formulations facility in Kothur village, Telangana.
Natco Pharma announced successful closure of inspection with an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) for the pre-approval inspection conducted at its drug formulations facility in Kothur village, Telangana, during the period from 2nd March to 6th March 2020.
The announcement was made on 25 April 2020. Shares of Natco Pharma rose 1.16% to close at Rs 624.35 on 24 April 2020.
Natco Pharma is a pharmaceutical company. The company has seven manufacturing facilities spread across India with research laboratories, capabilities in New Drug Development, etc.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
